Quick Answer
Sanofi reported Total Assets of $126.81 billion for fiscal year 2025.
Sanofi — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Assets | $126.81B -4.5% |
$132.80B +5.0% |
$126.46B -0.2% |
$126.72B +5.4% |
$120.24B +5.1% |
$114.41B +1.6% |
| R&D Expense | $7.84B +6.1% |
$7.39B +13.6% |
$6.51B +0.1% |
$6.50B +14.2% |
$5.69B +2.9% |
$5.53B -8.1% |
| Gross Profit | $33.67B +8.3% |
$31.08B +7.2% |
$28.99B +1.1% |
$28.68B +6.5% |
$26.92B +6.8% |
$25.21B -1.7% |
- Sanofi reported Total Assets of $126.81 billion for fiscal year 2025.
- Sanofi showed a decrease of -4.5% in Total Assets compared to the prior fiscal year.
- Sanofi reported R&D Expense of $7.84 billion for fiscal year 2025.
- Sanofi showed an increase of +6.1% in R&D Expense compared to the prior fiscal year.
- Sanofi reported Gross Profit of $33.67 billion for fiscal year 2025.
- Sanofi showed an increase of +8.3% in Gross Profit compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: